{
  "id": 5100502,
  "title": "Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute",
  "url": "https://urgent.news/2026/09/02/teva-claims-success-in-celiac-study-biomarin-ascendis-settle-patent",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T14:12:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/teva-celiac-biomarin-ascendis-gsk-flu-biontech-mifepristone/828937/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Teva believes the therapy has “pipeline-in-a-product” potential. Elsewhere, a high-stakes trial was paused and GSK advanced a competitor to Moderna’s flu shot.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Teva says gluten challenge study succeeds in celiac disease",
        "url": "https://urgent.news/2026/09/02/teva-says-gluten-challenge-study-succeeds-in-celiac-disease",
        "published": "2026-09-02T14:58:42.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}